Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-02-29
1982-09-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Lymphokine
424324, A61K 3178, A61K 31165
Patent
active
043518265
ABSTRACT:
Cataract formation in mammalian lenses can be prevented or reversed by applying a solution of an aldehyde, an acrylamide or a glycol to the lens under conditions that permit the solution to interact with the lens constituents.
REFERENCES:
patent: 3920810 (1975-11-01), Rankin
patent: 3927206 (1975-12-01), Blank et al.
Stedman's Medical Dictionary, 23 Ed., pp. 236-237, (1976), Williams & Wilkins Co.
Benedek George B.
Clark John I.
Mengel Loretta S.
Cook Paul J.
Massachusetts Institute of Technology
Robinson Douglas W.
Smith, Jr. Arthur A.
LandOfFree
Process for preventing or reversing cataract formation using acr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preventing or reversing cataract formation using acr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preventing or reversing cataract formation using acr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-399595